Tradition Wealth Management’s iShares Genomics Immunology and Healthcare ETF IDNA Stock Holding History

Tradition Wealth Management’s Portfolio IDNA Stock Details IDNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-756	Closed	-$17K	–	764
2023 Q4	$17K	Buy	756 +502	+198%	+$10.1K	﹤0.01%	882
2023 Q3	$5K	Hold	254	–	–	﹤0.01%	1181
2023 Q2	$6K	Buy	254 +1	+0.4%	+$24	﹤0.01%	1159
2023 Q1	$6K	Hold	253	–	–	﹤0.01%	1112
2022 Q4	$6K	Hold	253	–	–	﹤0.01%	1012
2022 Q3	$7K	Hold	253	–	–	﹤0.01%	1005
2022 Q2	$7K	Buy	253 +1	+0.4%	+$30	﹤0.01%	897
2022 Q1	$9K	Hold	252	–	–	﹤0.01%	921
2021 Q4	$11K	Buy	252 +2	+0.8%	+$95	﹤0.01%	893
2021 Q3	$13K	Hold	250	–	–	﹤0.01%	839
2021 Q2	$13K	Hold	250	–	–	﹤0.01%	873
2021 Q1	$11K	Hold	250	–	–	﹤0.01%	773
2020 Q4	$11K	Buy	+250	New	+$10.8K	﹤0.01%	706

Other funds holding IDNA

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

WBG

Wharton Business Group Malvern, Pennsylvania $2.65B AUM 20.73% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

CCA

Clearwater Capital Advisors Hoffman Estates, Illinois $1.24B AUM 15.23% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

Tradition Wealth Management's IDNA Position: Q1 2024 in Review

Tradition Wealth Management sold out of iShares Genomics Immunology and Healthcare ETF (IDNA) in Q1 2024, closing a stake of 756 shares — an estimated $17K sold.

Tradition Wealth Management first reported a position in IDNA in Q4 2020 and held it in 13 quarters. The position peaked at $17K in Q4 2023. 63 funds tracked by Wall St. Rank hold IDNA as of Q1 2024.

Tradition Wealth Management reported no remaining iShares Genomics Immunology and Healthcare ETF position as of Q1 2024 after selling out during the quarter.
Tradition Wealth Management sold 756 iShares Genomics Immunology and Healthcare ETF shares in Q1 2024, an estimated $17K.
Tradition Wealth Management first reported a position in iShares Genomics Immunology and Healthcare ETF in Q4 2020 and held it in 13 quarters.
Tradition Wealth Management's iShares Genomics Immunology and Healthcare ETF position peaked at $17K in Q4 2023.
63 funds tracked by Wall St. Rank held iShares Genomics Immunology and Healthcare ETF as of Q1 2024.

Based on Tradition Wealth Management's 13F filing for Q1 2024, filed 13 May 2024.